Clinical Trial Evaluating a Hyaluronic Acid Matrix in the Treatment of Chronic Non-healing Diabetic Foot Ulcers (DFUs)

NAUnknownINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

December 1, 2023

Study Completion Date

December 31, 2023

Conditions
Diabetic Foot
Interventions
DEVICE

Hēlaquis Matrix is a hyaluronic acid matrix (HaM)

Hēlaquis Matrix is a hyaluronic acid matrix (HaM) derived from the American Alligator and indicated for the treatment of chronic wounds. Hyaluronic Acid (HA) is a naturally occurring non sulphated glycosaminoglycan consisting of a linear sequence of D-glucuronic and N -acetyl-Dglucosamine. It is present in connective tissue and plays a role in several biological processes including tissue repair.

Sponsors
All Listed Sponsors
collaborator

Lacerta Life Sciences, LLC

UNKNOWN

lead

SerenaGroup, Inc.

NETWORK